Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)
European Journal of Cancer · 2026-08 · 244 · 116878
DOI: 10.1016/j.ejca.2026.116878 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-08. Verfasst von Théo Erard und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dermatologie, Centre hospitalier universitaire de Besançon, INSERM UMR 1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France k Dermatologie…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Immune Checkpoint Inhibitors, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatologie, Centre hospitalier universitaire de Besançon, INSERM UMR 1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France k Dermatologie, Hôpital Henri-Mondor AP-HP, Créteil, France.
- Service de dermatologie, CHU de Nantes, Université de Nantes, CIC 1413T, Inserm UMR 1302/EMR6001 INCI, Nantes, France.
- Dermatologie, Centre Léon Bérard, Lyon, France.
- Dermatologie, Hôpital l'Archet, Nice, France.
- Dermatologie, CHU Grenoble Alpes, La Tronche, France.
- uMETh, CIC, CHU, Besançon 1431, France.
Zitieren
APA
Erard, T., Quéreux, G., Amini-Adle, M., Montaudié, H., Charles, J., Puyraveau, M., Jeudy, G., Bernard, P., Grange, F., Legoupil, D., Zehou, O., Celerier, P., Lesage, C., Khammari, A., Aubin, F., & Nardin, C. (2026). Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS). European Journal of Cancer, 244, 116878. https://doi.org/10.1016/j.ejca.2026.116878
Vancouver
Erard T, Quéreux G, Amini-Adle M, Montaudié H, Charles J, Puyraveau M, et al. Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS). European Journal of Cancer. 2026;244:116878. doi:10.1016/j.ejca.2026.116878
BibTeX
@article{Erard2026,
author = {Erard, Théo and Quéreux, Gaelle and Amini-Adle, Mona and Montaudié, Henri and Charles, Julie and Puyraveau, Marc and Jeudy, Géraldine and Bernard, Philippe and Grange, Florent and Legoupil, Delphine and Zehou, Ouidad and Celerier, Philippe and Lesage, Candice and Khammari, Amir and Aubin, François and Nardin, Charlée},
title = {Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)},
journal = {European Journal of Cancer},
year = {2026},
volume = {244},
pages = {116878},
doi = {10.1016/j.ejca.2026.116878}
}
EUVIMED